XSpray Pharma AB (OSTO:XSPRAY) Days Payable : 0.00 (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is XSpray Pharma AB Days Payable?

XSpray Pharma AB's average Accounts Payable for the three months ended in Sep. 2024 was kr12.94 Mil. XSpray Pharma AB's Cost of Goods Sold for the three months ended in Sep. 2024 was kr0.00 Mil.

The historical rank and industry rank for XSpray Pharma AB's Days Payable or its related term are showing as below:

During the past 9 years, XSpray Pharma AB's highest Days Payable was 56.60. The lowest was 56.60. And the median was 56.60.

OSTO:XSPRAY's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 127.14
* Ranked among companies with meaningful Days Payable only.

XSpray Pharma AB's Days Payable stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00). stayed the same

XSpray Pharma AB Days Payable Historical Data

The historical data trend for XSpray Pharma AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XSpray Pharma AB Days Payable Chart

XSpray Pharma AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

XSpray Pharma AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of XSpray Pharma AB's Days Payable

For the Biotechnology subindustry, XSpray Pharma AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XSpray Pharma AB's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XSpray Pharma AB's Days Payable distribution charts can be found below:

* The bar in red indicates where XSpray Pharma AB's Days Payable falls into.

XSpray Pharma AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

XSpray Pharma AB's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (14.786	+	12.472)	/	2 )	/	0	*	365
=	13.629					/	0	*	365
=	N/A

XSpray Pharma AB's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (6.651	+	19.229)	/	2 )	/	0	*	365 / 4
=	12.94					/	0	*	365 / 4
=	N/A

XSpray Pharma AB Days Payable Related Terms

Thank you for viewing the detailed overview of XSpray Pharma AB's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

XSpray Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XSpray Pharma AB (OSTO:XSPRAY) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

6XP:Germany

Address

Scheeles vag 2, Solna, SWE, SE-171 65

Website

https://www.xspraypharma.com

XSpray Pharma AB is a pharmaceutical company focused on developing improved PKIs for cancer treatment, leveraging its proprietary HyNap technology platform. The company aims to enhance clinical outcomes for cancer patients by improving the efficacy, safety, and patient experience of existing cancer therapies. Its product portfolio includes Dasynoc and other product candidates in different stages of development such as XS003 nilotinib, XS008 axitinib, and XS00Y.

XSpray Pharma AB Headlines

No Headlines